Transitional cell carcinoma (TCC) is the most common type of bladder cancer in dogs.
Immune cells (known as T cells) are taken from the peripheral blood, stimulated, expanded and genetically modified in the laboratory to express a surface receptor that recognizes B cells
Determine whether a cell based vaccine can prevent the return of lymphoma after standard chemotherapy treatment.
This trial evaluates the safety and effectiveness of an antibody therapy designed to inhibit VEGF and delay or prevent spread of hemangioscarcoma after surgery
In this trial, we will be comparing I’m-Yunity’s® effect on survival time and quality of life to the standard chemotherapy treatment.
Seeking dogs with specific tumors to help us further cancer research
Clinical trial evaluating surgery in combination with immunotherapy for cats with fibrosarcoma
Further evaluation of the Listeria vaccine in dogs with osteosarcoma
Penn Vet is conducting a study to determine if near-infrared imaging can improve the surgeon’s ability to see cancer and cancer margins during surgery to remove feline soft tissue sarcomas.